Literature DB >> 10373578

A clean data set of EST-confirmed splice sites from Homo sapiens and standards for clean-up procedures.

T A Thanaraj1.   

Abstract

A clean data set of verified splice sites from Homo sapiens are reported as well as the standards used for the clean-up procedure. The sites were validated by: (i) standard cleaning procedures such as requiring consistency in the annotation of the gene structural elements, completeness of the coding regions and elimination of redundant sequences; (ii) clustering by decision trees coupled with analysis of ClustalW alignments of the translated protein sequence with homologous proteins from SWISS-PROT; (iii) matching against human EST sequences. The sites are categorised as: (i) donor sites, a set of 619 EST-confirmed donor sites, for which 138 are either the sites or the regions around the sites involved in alternative splice events; (ii) acceptor sites, a set of 623 EST-confirmed acceptor sites, for which 144 are either the sites or the regions around the sites are involved in alternative splice events; (iii) genuine splice sites, a set of 392 splice sites wherein both the donor and acceptor sites had EST confirmation and were not involved in any alternative splicing; (iv) alternative splice sites, a set of 209 splice sites wherein both the donor and acceptor sites had EST confirmation and the sites or the regions around them were involved in alternative splicing. A set of nucleotide regions that can be used to generate a control set of false splice sites that have a high confidence of being non-functional are also reported.

Entities:  

Mesh:

Year:  1999        PMID: 10373578      PMCID: PMC148470          DOI: 10.1093/nar/27.13.2627

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  14 in total

1.  GBuilder--an application for the visualization and integration of EST cluster data.

Authors:  J Muilu; P Rodriguez-Tomé; A Robinson
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

2.  Positional characterisation of false positives from computational prediction of human splice sites.

Authors:  T A Thanaraj
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

3.  The contribution of exon-skipping events on chromosome 22 to protein coding diversity.

Authors:  W A Hide; V N Babenko; P A van Heusden; C Seoighe; J F Kelso
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

4.  EASED: Extended Alternatively Spliced EST Database.

Authors:  Heike Pospisil; Alexander Herrmann; Ralf H Bortfeldt; Jens G Reich
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

5.  Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions.

Authors:  T A Thanaraj; F Clark
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

6.  Analysis of canonical and non-canonical splice sites in mammalian genomes.

Authors:  M Burset; I A Seledtsov; V V Solovyev
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

7.  Intron-flanking EST-PCR markers: from genetic marker development to gene structure analysis in Rhododendron.

Authors:  Hui Wei; Yan Fu; Rajeev Arora
Journal:  Theor Appl Genet       Date:  2005-11-15       Impact factor: 5.699

8.  SpliceDB: database of canonical and non-canonical mammalian splice sites.

Authors:  M Burset; I A Seledtsov; V V Solovyev
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

9.  Analysis of the role of Caenorhabditis elegans GC-AG introns in regulated splicing.

Authors:  Tracy Farrer; A Brock Roller; W James Kent; Alan M Zahler
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

10.  Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans.

Authors:  Benjamin P Lewis; Richard E Green; Steven E Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.